34
Views
31
CrossRef citations to date
0
Altmetric
Original

GENDER DIFFERENCE IN THE RELATIONSHIPS AMONG HYPERLEPTINEMIA, HYPERINSULINEMIA, AND HYPERTENSION

, , , , , , , , , & show all
Pages 357-368 | Received 26 May 2000, Accepted 15 Nov 2000, Published online: 31 May 2001

REFERENCES

  • Pelleymounter M A, Cullen M J, Baker M B, Hecht R, Winters D, Boone T, Collins F. Effects of the ob gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540–543
  • Halaas J L, Gajiwala K S, Maffei M, Cohn S L, Chait B T, Rabinowitz D, Lallone R L, Burley S K, Freidman J N. Weight reduction efects of the plasma protein encoded by the obese gene. Science 1995; 269: 543–546
  • Haynes W G, Mogan D A, Walsh S A, Mark A L, Sivitz W I. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278
  • Shek E W, Brands M W, Hall J E. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–414
  • Snitker S, Pratley R E, Nicolson M, Tataranni P A, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obesity Research 1997; 5: 338–340
  • Narkiewics K, Somers V K, Mos L, Kato M, Accurso V, Palatini P. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens 1999; 17: 245–249
  • De Fronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1994; 14: 173–194
  • Considine R V, Sinha M K, Heiman M L, Kriauciunas A, Stephens T W, Nyce M R, Ohannesian J P, Marco C C, McKee L J, Bauer T L, Caro J F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295
  • Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377: 527–529
  • Boden G, Chen X, Kolaczynski J W, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997; 100: 1107–1113
  • Kim-Motoyama H, Yamaguchi T, Katakura T, Miura M, Ohashi Y, Yazaki Y, Kadowaki T. Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. Biochem Biophys Res Comm 1997; 239: 340–344
  • Leyva F, Godsland I F, Ghatei M, Proudler A J, Aldis S, Walton C, Bloom S, Stevenson J C. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928–933
  • Hirose H, Saito I, Tsujioka M, Mori M, Kawabe H, Saruta T. The obese gene product, leptin: possible role in obesity-related hypertension in adolescents. J hypertens 1998; 16: 2007–2012
  • Soderberg S, Olsson T, Eliasson M, Johnson O, Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med, 1999; 245: 533–543
  • Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoactive leptin level in essential hypertension. J Hypertens. 1997; 10: 1171–1174
  • de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti K GMM. Hyperleptinemia: the missing link in the metabolic syndrome?. Diabetic Med. 1997; 14: 200–208
  • Haffner S M, Mykkanen L, Rainwater D L, karhapaa P, Laakso M. Is leptin concentration associated with the insulin resistance syndrome in non diabetic men?. Obesity Res. 1999; 7: 164–169
  • Ma Z, Gingerich R L, Santiago J V, Klein S, Smith C H, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem. 1996; 42: 942–946
  • Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Tracher D F, Turner R C. Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
  • Oimatsu H, Saitoh S, Ura N, Shimamoto K. A practical index for evaluation of insulin resistance. J Japan Diab Soc. 2000; 43(3)205–213
  • Joint National Committee. The sixth report on the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-VI). Arch Intern Med. 1997; 157: 2413–2446
  • Agata J, Miyazaki Y, Takada M, Murakami H, Masuda A, Miura T, Ura N, Shimamoto K. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension. Hypertens Res. 1998; 21: 57–62
  • Lind L, Bern C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 1995; 13: 1457–1462
  • Urban J H, Bauer-Dantoin A C, Levine J E. Neuropeptide Y gene expression in the arcurate nucleus: sexual dimorphism and modulation by testosterone. Endocrinology 1993; 132: 139–145
  • Barnett S R, Morin R J, Kiely D K, Gagnon M, Azhar G, Knight E L, Nelson JC, Lipsitz L A. Effects of age and gender on autonomic control of blood pressure dynermics. Hypertension 1999; 33: 1195–1200
  • Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism: Clinical & Experimental 1987; 36: 54–59
  • Kissebah A H, Krakower G R. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761–811
  • Kanai H, Tokunaga K, Fujioka S, Yamashita S, Kameda-Takemura K, Matsuzawa Y. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 1996; 27: 125–129
  • Montague C T, Prins J B, sanders L, Digby J E, O’Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342–347
  • Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens. 1998; 16: 1475–1480
  • Bouloumie A, Marumo K, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999; 13: 1231–1238
  • Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am J Clin Nutr. 1996; 64(suppl)524S–532S

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.